Evidence map›Paper›PMID 27104346›Full record

Trial reportPloS one2016

Mechanisms of Attenuation of Pulmonary V'O2 Slow Component in Humans after Prolonged Endurance Training.

Jerzy A Zoladz, Joanna Majerczak, Bruno Grassi, Zbigniew Szkutnik, Michał Korostyński, Sławomir Gołda, Marcin Grandys, Wiesława Jarmuszkiewicz, Wincenty Kilarski, Janusz Karasinski and 1 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Frontiers in physiology · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Effects of chronic nitric oxide synthase inhibition on V'ONaunyn-Schmiedeberg's archives of pharmacology · 2017
    Article
  7. Article
  8. Endurance training increases the efficiency of rat skeletal muscle mitochondria.Pflugers Archiv : European journal of physiology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Jerzy A ZoladzDepartment of Muscle Physiology, Chair of Physiology and Biochemistry, Faculty of Rehabilitation, University School of Physical Education, Krakow, Poland.
Joanna MajerczakDepartment of Muscle Physiology, Chair of Physiology and Biochemistry, Faculty of Rehabilitation, University School of Physical Education, Krakow, Poland.
Bruno GrassiDipartimento di Scienze Mediche e Biologiche, Università degli Studi di Udine, Udine, Italy.
Zbigniew SzkutnikFaculty of Applied Mathematics, AGH-University of Science and Technology, Krakow, Poland.
Michał KorostyńskiDepartment of Molecular Neuropharmacology, Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.
Sławomir GołdaDepartment of Molecular Neuropharmacology, Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland.
Marcin GrandysDepartment of Muscle Physiology, Chair of Physiology and Biochemistry, Faculty of Rehabilitation, University School of Physical Education, Krakow, Poland.
Wiesława JarmuszkiewiczDepartment of Bioenergetics, Institute of Molecular Biology and Biotechnology, Adam Mickiewicz University, Poznan, Poland.
Wincenty KilarskiDepartment of Cell Biology and Imaging, Institute of Zoology, Jagiellonian University, Krakow, Poland.
Janusz KarasinskiDepartment of Cell Biology and Imaging, Institute of Zoology, Jagiellonian University, Krakow, Poland.
Bernard KorzeniewskiFaculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
Jagiellonian University · PLUniversity School of Physical Education in Kraków · PLAdam Mickiewicz University in Poznań · PLAGH University of Krakow · PLMaj Institute of Pharmacology · PLPolish Academy of Sciences · PLUniversity of Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study we have examined the effect of prolonged endurance training program on the pulmonary oxygen uptake (V'O2) kinetics during heavy-intensity cycling-exercise and its impact on maximal cycling and running performance. Twelve healthy, physically active men (mean±SD: age 22.33±1.44 years, V'O2peak 3198±458 mL ∙ min-1) performed an endurance training composed mainly of moderate-intensity cycling, lasting 20 weeks. Training resulted in a decrease (by ~5%, P = 0.027) in V'O2 during prior low-intensity exercise (20 W) and in shortening of τp of the V'O2 on-kinetics (30.1±5.9 s vs. 25.4±1.5 s, P = 0.007) during subsequent heavy-intensity cycling. This was accompanied by a decrease of the slow component of V'O2 on-kinetics by 49% (P = 0.001) and a decrease in the end-exercise V'O2 by ~5% (P = 0.005). An increase (P = 0.02) in the vascular endothelial growth factor receptor 2 mRNA level and a tendency (P = 0.06) to higher capillary-to-fiber ratio in the vastus lateralis muscle were found after training (n = 11). No significant effect of training on the V'O2peak was found (P = 0.12). However, the power output reached at the lactate threshold increased by 19% (P = 0.01). The power output obtained at the V'O2peak increased by 14% (P = 0.003) and the time of 1,500-m performance decreased by 5% (P = 0.001). Computer modeling of the skeletal muscle bioenergetic system suggests that the training-induced decrease in the slow component of V'O2 on-kinetics found in the present study is mainly caused by two factors: an intensification of the each-step activation (ESA) of oxidative phosphorylation (OXPHOS) complexes after training and decrease in the ''additional" ATP usage rising gradually during heavy-intensity exercise.

Indexed as

Blotting, WesternComputer SimulationExerciseExercise TestGene ExpressionHeart RateHumansLactatesLungMaleModels, BiologicalMuscle ProteinsOxidative PhosphorylationOxygen ConsumptionPhysical EnduranceQuadriceps MuscleATP2A1 protein, humanATP2A2 protein, humanLactatesMuscle ProteinsSarcoplasmic Reticulum Calcium-Transporting ATPasesVascular Endothelial Growth Factor A

Identifiers

PMID27104346
PMCPMC4841588
OpenAlexW2339719594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.